| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2004 : ECCMID 2004 : Use of an in vitro Pharmacodynamic Model & Monte Carlo Simulation to Characterize the Pharmacokinetics and Pharmacodynamics of Gatifloxacin vs Salmonella Typhi | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: B.M. Booker The University at Buffalo School of Pharmacy and Pharmaceutical Sciences Applied Pharmacodynamics Laboratory, Roswell Park Cancer Institute, Buffalo, NY Cognigen Primary Author: P.G. Ambrose
Primary Author: B.M. Booker The University at Buffalo School of Pharmacy and Pharmaceutical Sciences Applied Pharmacodynamics Laboratory, Roswell Park Cancer Institute, Buffalo, NY
Event: ESCMID 2004 Prague, Czech Republic
Cognigen Primary Author: P.G. Ambrose
Other Contributors:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences Applied Pharmacodynamics Laboratory
P.F. Smith, A. Forrest, J. Bullock, P. Kelchlin, S.M. Bhavnani
Roswell Park Cancer Institute, Buffalo, NY
P.F. Smith
Cognigen Corporation, Buffalo, NY
S.M. Bhavnani
The JONES Group/JMI Laboratories, North Liberty, IA
R.N. Jones
Tuft's University School of Medicine, Boston, MA
R.N. Jones
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2004 : ECCMID 2004 : Use of an in vitro Pharmacodynamic Model & Monte Carlo Simulation to Characterize the Pharmacokinetics and Pharmacodynamics of Gatifloxacin vs Salmonella Typhi | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |